News & Events

$1,000 OFF Any Gene Targeting Project

Get started on your gene editing project as the year comes to a close! As the holiday season approaches, we are thrilled to offer you…

Read more
Check out our poster at 15th Annual PEGS Europe: Nov 14-16

Join us at the 15th Annual PEGS Europe in Lisbon, Portugal from Nov 14-16! Don't miss our poster session featuring Anti-TROP2 x EGFR Bispecific ADC…

Read more
SITC 2023 Highlights: Biocytogen’s Novel Assets and Products

The Biocytogen team concluded a successful SITC 2023 event, after presenting 9 drug asset posters, 7 genetically engineered mouse model posters, and connecting with current…

Read more
Join us at the Neuroscience 2023: Nov 11-15

Join us at Neuroscience 2023 in Washington, D.C. from Nov 11-15! Visit booth #637 to chat with our team and learn about our preclinical animal…

Read more
Discover the Future of Antibody/TCR-based Therapeutics: Meet Biocytogen’s Licensing Team at BIO-EUROPE 2023!

Biocytogen will be exhibiting and hosting 1-on-1 meetings at BIO-EUROPE 2023, taking place from November 6-8, 2023 in Munich, Germany. Biocytogen is thrilled to be…

Read more
Webinar: Generation of TCR-mimic antibodies targeting intracellular proteins to expand the druggable target repertoire for anti-tumor therapies

Our webinar “Generation of TCR-mimic antibodies targeting intracellular proteins to expand the druggable target repertoire for anti-tumor therapies" was live at 12:00 PM EST on Nov…

Read more
Biocytogen/Eucure Biopharma to Present Complete Clinical Data from YH003 (anti- CD40 mAb) Phase I Trial at ESMO 2023

Beijing, China, Oct 16, 2023 - Eucure Biopharma, a wholly owned subsidiary of Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315), will attend and present…

Read more
Visit our Booth and Bispecific ADC Posters at World ADC San Diego: Oct 17-18

Biocytogen’s BD team is excited to exhibit and attend the 14th Annual World ADC San Diego conference, taking place from Oct 17–18, 2023! Be sure…

Read more
Webinar: Predicting Toxicity of Immuno-Oncology Drug Candidates: Preclinical Platforms to Evaluate Toxicology In Vivo and Ex Vivo

Our webinar “Predicting Toxicity of Immuno-Oncology Drug Candidates: Preclinical Platforms to Evaluate Toxicology In Vivo and Ex Vivo" was live at 12:00 PM EDT on Oct…

Read more
Join us at the Festival of Biologics Europe 2023: Oct 10-12

Join us at the Festival of Biologics Europe 2023 in Basel, Switzerland from Oct 10-12! Stop by booth #703 and learn about our preclinical animal…

Read more
Back to top